Cognition Therapeutics (CGTX) Exchange Rate Effect (2020 - 2023)
Cognition Therapeutics (CGTX) posted quarterly Exchange Rate Effect of $1000.0 for Q3 2023, up 133.33% year-over-year from $428.57 in Q3 2022, and up 200.0% quarter-over-quarter from -$1000.0 in Q2 2023.
Cognition Therapeutics (CGTX) Exchange Rate Effect (2020 - 2023) Analysis & Trends
Cognition Therapeutics (CGTX) has reported Exchange Rate Effect for 4 consecutive years, with $1000.0 the latest figure, recorded in Q3 2023.
- In Q3 2023, Exchange Rate Effect rose 133.33% year-over-year to $1000.0; the TTM figure through Dec 2023 stood at $4000.0 (up 500.0% YoY), while the FY2023 annual figure was $4000.0, up 500.0% from the prior year.
- Exchange Rate Effect rose to $1000.0 in Q3 2023 per CGTX's latest filing, from -$1000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $21000.0 in Q3 2021 and bottomed at -$24000.0 in Q4 2021.
- Historically, Exchange Rate Effect has averaged -$1900.0 across 4 years, with a median of $0.0 in 2022.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect plunged 114.29% — and 2023, when it soared 300.0%.
- Cognition Therapeutics' Exchange Rate Effect stood at -$19000.0 in 2020, then declined by 26.32% to -$24000.0 in 2021, then soared by 116.67% to $4000.0 in 2022, then slumped by 75.0% to $1000.0 in 2023.
- Business Quant data shows CGTX's Exchange Rate Effect at $1000.0 in Q3 2023, -$1000.0 in Q2 2023, and $4000.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.94 Bn | 132.09 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.59 Bn | 78.60 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 65.67 Bn | 60.49 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.81 Bn | 52.67 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 42.25 Bn | 37.15 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.76 Bn | 28.45 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 28.41 Bn | 10.02 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.24 Bn | 26.41 Bn | - | - |
| 10 | Cognition Therapeutics | 90.21 Mn | 90.21 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 1,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2023 | -1,000.00 |
| Jun 30, 2023 | -1,000.00 |
| Mar 31, 2023 | 4,000.00 |
| Mar 31, 2023 | 4,000.00 |
| Dec 31, 2022 | 4,000.00 |
| Dec 31, 2022 | 4,000.00 |
| Sep 30, 2022 | -3,000.00 |
| Sep 30, 2022 | -3,000.00 |
| Jun 30, 2022 | -3,000.00 |
| Jun 30, 2022 | -3,000.00 |
| Mar 31, 2022 | 1,000.00 |
| Mar 31, 2022 | 1,000.00 |
| Dec 31, 2021 | -24,000.00 |
| Dec 31, 2021 | -24,000.00 |
| Sep 30, 2021 | 21,000.00 |
| Sep 30, 2021 | 21,000.00 |
| Dec 31, 2020 | -19,000.00 |
| Dec 31, 2020 | -19,000.00 |